CAS: 63659-17-6; 2-[[4-[2-(Cyclopropylmethoxy)Ethyl]Phenoxy]Methyl]Oxirane

该化合物是一种有机化合物,其特征是三环环醚,由三者组成.该化合物具有苯氧组,表明存在一种苯酚衍生物,并存在一种环丙基苯氧组,有助于其独特的结构特性.但该氧化物环的存在表明,它可能呈现出一种四氧化物的再活动性典型,例如,在出现核分裂物时正在发生环状开关反应.该环状体组可影响该化合物的消毒性和电子特性,有可能影响其与生物系统的再活动性和相互作用.此外,该化合物的分子结构表明有可能在医药化学或有机合成的中间体中应用.然而,某些具体的物理特性,如沸点,熔点和溶解性,需要实证数据来精确地定性.

结构式图片

上下游产品

4-[2-(cyclopropylmethoxy)-ethyl]-phenol epichlorohydrin 1,2-Epoxy-3-bromopropane 1-allyloxy-4-(2-cyclopropylmethoxyethyl)benzene

合成工艺路线路线简述

    2-(4-苯甲氧基苯基)乙醇置于palladium On Activated Charcoal Sodium Hydroxide,氢气,Sodium Hydride体系中,用 四氢呋喃,水 作为反应溶剂,25.0~60.0 °C,344.73 Kpa 条件下,反应 30.0H,反应生成 1-{4-[2-(环丙基甲氧基)-乙基]-苯氧基}-2,3-环氧丙烷
    参考文献:Synthesis Of A Series Of Compounds Related To Betaxolol,A New .Beta.1-Adrenoceptor Antagonist With A Pharmacological And Pharmacokinetic Profile Optimized For The Treatment Of Chronic Cardiovascular Diseases
    标题:Synthesis Of A Series Of Compounds Related To Betaxolol,A New .Beta.1-Adrenoceptor Antagonist With A Pharmacological And Pharmacokinetic Profile Optimized For The Treatment Of Chronic Cardiovascular Diseases
    摘要:A Series Of Para-Substituted Phenoxypropanolamines Has Been Synthesized And Tested For Beta-Adrenoceptor Blocking Activity. Some Derivatives (8,11,12,20,21) Exhibited Greater In Vitro Potency Than The Reference Drugs Metoprolol And Propranolol. This Series,In Contrast To Propranolol But Similar To Metoprolol,Possesses Cardioselectivity. The 3-[p-[(Cycloalkylmethoxy)Ethyl]Phenoxy]-1-Substituted-Amino-2-Prop Anol Derivatives 8 (Cyclopropylmethoxyethyl: Betaxolol) And 11 (Cyclobutylmethoxyethyl) Produced Antihypertensive Effects In Spontaneously Hypertensive Rats. Betaxolol (Kerlon,8) Was Found To Exhibit An Appropriate Preclinical Pharmacological And Human Pharmacokinetic Profile (Elevated Oral Bioavailability And Prolonged Plasma Half-Life) For The Treatment Of Chronic Cardiovascular Diseases Such As Hypertension And Angina.
    DOI:10.1021/jm00389A008

    海关参考信息

    专利信息


    专利号:US-2021154202-A1
    优先权日:2018-04-17
    标 题:Synthesis of dentimol, an antiglaucoma drug
    发明人:LANCINA MICHAEL; WANG JUAN; YANG HU
    权利人:UNIV VIRGINIA COMMONWEALTH
    摘要:Compounds, comprising a selective β-blocker coupled to a PAMAM dendrimer via a flexible spacer, and compositions containing the compounds, are provided. Methods of making and using the compounds and compositions for the treatment of glaucoma and other maladies are also provided.
    济南德诚和牧医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jndecheng.com
    企业联系电话:0531-62325949 18615171096👤
    📞济南德诚和牧医药科技有限公司 ⚠️参考联系方式
    联系人:肖经理
    电话:0531-62325949 18615171096
    手机:18615171096
    传真:0531-68658860
    邮箱:dcyy@vip.sina.com
    通信地址: 山东省济南市高新区留学人员创业园2号楼
    邮编: 250100
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:山东省济南市高新区留学人员创业园2号楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Design And Synthesis Of A Series Of Combined Vasodilator-.Beta.-Adrenoceptor Antagonists Based On 6-Arylpyridazinones
    作者:R. A. Slater,W. Howson,G. T. G. Swayne,E. M. Taylor,D. R. Reavill |发布日期:1988.2
    摘要:Synthesized And Evaluated As Combined Vasodilator/beta-Adrenoceptor Antagonists And Potential Antihypertensive Agents. Many Of The Early Compounds Displayed An Unacceptably High Level Of Intrinsic Sympathomimetic Activity (Isa) And A Relatively Short Duration Of Action. Disubstitution In The 2,3-Positions Or In The 4-Position Of The Aryloxy Ring Gave Compounds With Low Isa Levels And, In Some Instances,

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知